Evaluating the eye health benefits of black tomato extract
Evaluation of Eye Health Benefits of Black Tomato Extract
This study tests if black tomato extract can help improve eye health for people with high myopia who often feel dryness and fatigue from using digital devices.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | TCI Co., Ltd. Industry-sponsored |
| Locations | 1 site (Taichung) |
| Trial ID | NCT06412393 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the efficacy of black tomato extract in improving eye health, particularly for individuals suffering from high myopia. Participants will be administered either black tomato extract powder or a placebo powder to determine the extract's potential benefits. The study focuses on individuals who use digital devices extensively and experience symptoms like dryness and fatigue in their eyes. The trial will involve monitoring participants' eye health over a specified period to evaluate any improvements.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 20 years old with high myopia and significant daily screen time.
Not a fit: Patients with a history of eye surgery or systemic diseases affecting eye health may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a natural supplement option for individuals with high myopia to improve their eye health.
How similar studies have performed: While the specific use of black tomato extract is novel, similar studies on natural supplements for eye health have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than 20 and capable of providing informed consent. * Daily usage of 3C (computer, communication, and consumer electronics) for more than 6 hours (OSDI screening - those experiencing dryness and fatigue in the eyes). * BMI between 22 and 35. * High myopia population (-5.00 to -9.00D) Exclusion Criteria: * History of any eye surgery (e.g., strabismus surgery, refractive surgery). * Presence of systemic diseases affecting the anterior surface of the eye. * Long-term use of medications affecting the anterior surface of the eye.
Where this trial is running
Taichung
- Chung Shan Medical University — Taichung, Taiwan (Recruiting)
Study contacts
- Principal investigator: Bo-Yie Chen boychen@csmu.edu.tw — Chung Shan Medical University
- Study coordinator: Bo-Yie Chen
- Email: boychen@csmu.edu.tw
- Phone: +886-04-24730022
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.